NEW ORLEANS, LA—Intravenous tenecteplase (TNKase; Genentech) improves functional outcomes versus standard care when ...

The inaugural event, lasting 2 days, features deep dives into technical skills, as well as new data and discussion among ...

There’s a lot of nuance in the numbers, though—only diets with a lot of healthy, nutrient-dense foods came out as winners.

With five phases of advancement, teams can become successful working through each type of case, from simple to complex.

The implication, some say, is that when TAVI expanded to lower-risk patients in 2019, death rates rose—not so fast, say ...

Rural areas may be more affected by adverse social and environmental factors than urban areas, Mitchell Elkind says.

TCTMD spoke with Lior Jankelson, MD, PhD (NYU Langone Health, New York, NY), an electrophysiologist who leads the AI/machine ...

NEW ORLEANS, LA—Adding the factor XIa inhibitor asundexian (Bayer) to antiplatelet therapy tops antiplatelet therapy alone ...

Citing lack of robust trial data, the committee offers algorithms and advice on care considerations in premenopausal ...

Much of the onus for creating change should fall to the device and pharmaceutical companies themselves, one expert says.

By slicing and dicing the data, the study confirms MITRA-FR as an outlier and emphasizes the need for careful patient selection.

With the study adding to a mix of conflicting trial results, it’s not yet time to update guidelines, Shyam Prabhakaran says.